Quality Management System: User Interface Updates to Support HL7 R2 Requirements
Product: Windchill
Release: 11.1 M010
Benefit
Provides the capability to generate an enhanced version of HL7 report in conformance to the HL7 R2 submission requirements from Food and Drug Administration (FDA).
Additional Details
The support for HL7 R2 submission requirements, introduced in Windchill 11.1 F000, has been extended to update the application user interface to add new attributes. The patient information section in the Edit eMDR wizard has been updated to add new attributes for ethnicity and race.
Related Information
For more information, see
eMDR Process Overview.
